Gate News message, April 14 — Transcenta Holding Limited announced on April 15 that it entered into a placement agreement on April 14 (after trading hours) to place 5.085 million H shares (Hong Kong-listed shares) at HK$57.03 per share, representing an 18% discount to the closing price. The net proceeds are expected to reach approximately HK$282.15 million.
The company plans to allocate approximately 57% of the funds to R&D, including clinical development of its core product Tinengotinib for advanced breast cancer, hepatocellular carcinoma, castration-resistant prostate cancer, and TT-00973; about 33% to production and commercialization of Tinengotinib in China, including building a commercial team and marketing activities; and about 10% to working capital and general corporate purposes.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
Related Articles
Hope AI helps Taiwan’s game industry make a comeback! ZhiGuan Technology is bringing AI into copywriting, image, and music production
Following AI development center to promote generative AI and B2B and B2C applications, with the goal of improving company efficiency and player engagement, and hoping to turn things around. However, many players remain skeptical, worried that AI will only become a tool for cutting costs and will affect game quality.
CryptoCity3m ago
Silicon photonics concept stock Lianyah (3081) defaults on delivery, resulting in a breach of settlement totaling over NT$70 million—what are the conditions and risks for day trading?
Lianyi (3081) has seen a default settlement case involving NT$68.9M, stemming from a single investor’s mismanagement of their funds. Intraday trading allows investors to buy and sell the same underlying asset on the same day, but it must meet specific conditions; the risk is that insufficient funding liquidity may lead to losses. High-frequency traders need to carefully manage cash flow to avoid problems with short funds, and should establish a rational investment plan.
ChainNewsAbmedia5m ago
Broadcom Secures Expanded Meta Chip Deal as CEO Hock Tan Steps Down from Board to Advisory Role
Broadcom and Meta have extended their partnership until 2029, focusing on custom accelerators and AI chip development. The collaboration aims to empower billions through advanced computational infrastructure, while Broadcom's stock has risen significantly.
GateNews14m ago
TradFi Fall Alert: MINIMAX (MINIMAX-W 00100.HK) Falls Over 12%
Gate News: According to the latest Gate TradFi data, MINIMAX (MINIMAX-W 00100.HK) has dropped by 12% in a short period. Current volatility is significantly higher than recent averages, indicating increased market
GateNews15m ago
SoftBank Seeks Additional Banks for $40B OpenAI Loan, Inviting $5B Commitments
SoftBank has initiated a soft launch for a $40 billion bridge loan to finance its OpenAI investment, inviting other lenders to participate. This follows SoftBank's previous $30 billion investment in OpenAI and anticipated revenues of $11.6 billion by 2025.
GateNews38m ago
